Amarin Return on Equity

Amarin (AMRN) currently reports a ROE of -6.11%. That is below the Healthcare sector average of 21.67%. Use the charts on this page to explore Amarin's ROE history and peer comparisons.

Amarin's ROE of -6.11% is lower than the Healthcare sector average of 21.67%. That is roughly 128.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Amarin's current -6.11% should be judged against Healthcare norms (sector average: 21.67%) and against AMRN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -6.11%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.67%. From there, open related valuation or income-statement pages for Amarin, and consider following AMRN for alerts when major investors trade the stock.

Amarin is classified in the Healthcare sector. On ROE, it currently shows -6.11% versus a sector average near 21.67%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AMRN with unrelated industries.